MicroRNA-873 (MiRNA-873) inhibits glioblastoma tumorigenesis and metastasis by suppressing the expression of IGF2BP1

Journal of Biological Chemistry

Volumn 290, Issue 14, 2015, Pages 8938-8948

  Wang, Ren Jie ^a   Li, Jian Wei ^a   Bao, Bu He ^a   Wu, Huan Cheng ^a   Du, Zhen Hua ^a   Su, Jing Liang ^a   Zhang, Ming Hua ^a   Liang, Hai Qian ^a  

^a Pingjin Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROLIFERATION; DIAGNOSIS; GENE EXPRESSION; GENE EXPRESSION REGULATION; PATHOLOGY;

GLIOBLASTOMA MULTIFORME; GLIOBLASTOMAS; INHIBITION MECHANISMS; INTENSIVE RESEARCH; OVER-EXPRESSION; POTENTIAL TARGETS; TARGET GENES; TUMORIGENESIS;

RNA;

INSULIN LIKE GROWTH FACTOR 2 MRNA BINDING PROTEIN 1; MICRORNA; MICRORNA 873; SOMATOMEDIN B; UNCLASSIFIED DRUG; IMP-1 PROTEIN, HUMAN; MIRN873 MICRORNA, HUMAN; RNA BINDING PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; GENE EXPRESSION; GENE OVEREXPRESSION; GLIOBLASTOMA; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA STABILITY; RNA TRANSCRIPTION; TUMOR INVASION; ANIMAL; BAGG ALBINO MOUSE; BRAIN TUMOR; GENETICS; MOUSE; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; UPREGULATION;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; GLIOBLASTOMA; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASM METASTASIS; RNA-BINDING PROTEINS; UP-REGULATION;

EID: 84926432108     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.624700     Document Type: Article

References (38)

1. Gladson, C. L., Prayson, R. A., and Liu, W. M. (2010) The pathobiology of glioma tumors. Annu. Rev. Pathol. 5, 33-50
2. Kohler, B. A., Ward, E., McCarthy, B. J., Schymura, M. J., Ries, L. A., Eheman, C., Jemal, A., Anderson, R. N., Ajani, U. A., and Edwards, B. K. (2011) Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J. Natl. Cancer Inst. 103, 714-736
3. Furnari, F. B., Fenton, T., Bachoo, R. M., Mukasa, A., Stommel, J. M., Stegh, A., Hahn, W. C., Ligon, K. L., Louis, D. N., Brennan, C., Chin, L., DePinho, R. A., and Cavenee, W. K. (2007) Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 21, 2683-2710
4. Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., and Dirks, P. B. (2004) Identification of human brain tumour initiating cells. Nature 432, 396-401
5. Ohgaki, H., and Kleihues, P. (2005) Epidemiology and etiology of gliomas. Acta Neuropathol. 109, 93-108
6. Bartel, D. P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297
7. Ambros, V. (2004) The functions of animal microRNAs. Nature 431, 350-355
8. Ciafrè, S. A., Galardi, S., Mangiola, A., Ferracin, M., Liu, C. G., Sabatino, G., Negrini, M., Maira, G., Croce, C. M., and Farace, M. G. (2005) Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem. Biophys. Res. Commun. 334, 1351-1358
9. Chan, J. A., Krichevsky, A. M., and Kosik, K. S. (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 65, 6029-6033
10. Papagiannakopoulos, T., Shapiro, A., and Kosik, K. S. (2008) MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res. 68, 8164-8172
11. Gabriely, G., Yi, M., Narayan, R. S., Niers, J. M., Wurdinger, T., Imitola, J., Ligon, K. L., Kesari, S., Esau, C., Stephens, R. M., Tannous, B. A., and Krichevsky, A. M. (2011) Human glioma growth is controlled by microRNA-10b. Cancer Res. 71, 3563-3572
12. Tu, Y., Gao, X., Li, G., Fu, H., Cui, D., Liu, H., Jin, W., and Zhang, Y. (2013) MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1. Cancer Res. 73, 6046-6055
13. Hui, W., Yuntao, L., Lun, L., WenSheng, L., ChaoFeng, L., HaiYong, H., and Yueyang, B. (2013) MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1. PLoS One 8, e54932
14. Sun, G., Cao, Y., Shi, L., Sun, L., Wang, Y., Chen, C., Wan, Z., Fu, L., and You, Y. (2013) Overexpressed miRNA-137 inhibits human glioma cells growth by targeting Rac1. Cancer Biother. Radiopharm. 28, 327-334
15. Yang, T. Q., Lu, X. J., Wu, T. F., Ding, D. D., Zhao, Z. H., Chen, G. L., Xie, X. S., Li, B., Wei, Y. X., Guo, L. C., Zhang, Y., Huang, Y. L., Zhou, Y. X., and Du, Z. W. (2014) MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathway. Cancer Sci. 105, 265-271
16. Skalsky, R. L., and Cullen, B. R. (2011) Reduced expression of brain-enriched microRNAs in glioblastomas permits targeted regulation of a cell death gene. PLoS One 6, e24248
17. Gutschner, T., Hämmerle, M., Pazaitis, N., Bley, N., Fiskin, E., Uckelmann, H., Heim, A., Groß, M., Hofmann, N., Geffers, R., Skawran, B., Longerich, T., Breuhahn, K., Schirmacher, P., Mühleck, B., Hüttelmaier, S., and Diederichs, S. (2014) Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinoma. Hepatology 59, 1900-1911
18. Sotgia, F., Razani, B., Bonuccelli, G., Schubert, W., Battista, M., Lee, H., Capozza, F., Schubert, A. L., Minetti, C., Buckley, J. T., and Lisanti, M. P. (2002) Intracellular retention of glycosylphosphatidyl inositol-linked proteins in caveolin-deficient cells. Mol. Cell. Biol. 22, 3905-3926
19. Sparanese, D., and Lee, C. H. (2007) CRD-BP shields c-myc and MDR-1 RNA from endonucleolytic attack by a mammalian endoribonuclease. Nucleic Acids Res. 35, 1209-1221
20. Vikesaa, J., Hansen, T. V., Jønson, L., Borup, R., Wewer, U. M., Christiansen, J., and Nielsen, F. C. (2006) RNA-binding IMPs promote cell adhesion and invadopodia formation. EMBO J. 25, 1456-1468
21. Stöhr, N., Köhn, M., Lederer, M., Glass, M., Reinke, C., Singer, R. H., and Hüttelmaier, S. (2012) IGF2BP1 promotes cell migration by regulating MK5 and PTEN signaling. Genes Dev. 26, 176-189
22. Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., and Kleihues, P. (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 114, 97-109
23. Ohgaki, H., and Kleihues, P. (2005) Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J. Neuropathol. Exp. Neurol. 64, 479-489
24. Kanu, O. O., Hughes, B., Di, C., Lin, N., Fu, J., Bigner, D. D., Yan, H., and Adamson, C. (2009) Glioblastoma multiforme oncogenomics and signaling pathways. Clin. Med. Oncol. 3, 39-52
25. Ostrom, Q. T., and Barnholtz-Sloan, J. S. (2011) Current state of our knowledge on brain tumor epidemiology. Curr. Neurol. Neurosci. Rep. 11, 329-335
26. Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., Taphoorn, M. J., Janzer, R. C., Ludwin, S. K., Allgeier, A., Fisher, B., Belanger, K., Hau, P., Brandes, A. A., Gijtenbeek, J., Marosi, C., Vecht, C. J., Mokhtari, K., Wesseling, P., Villa, S., Eisenhauer, E., Gorlia, T., Weller, M., Lacombe, D., Cairncross, J. G., Mirimanoff, R. O., European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups, and National Cancer Institute of Canada Clinical Trials Group (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 10, 459-466
27. Kang, M. K., and Kang, S. K. (2007) Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma. Stem Cells Dev. 16, 837-847
28. Conti, A., Aguennouz, M., La Torre, D., Tomasello, C., Cardali, S., Angileri, F. F., Maio, F., Cama, A., Germanò, A., Vita, G., and Tomasello, F. (2009) miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors. J. Neurooncol. 93, 325-332
29. Guessous, F., Alvarado-Velez, M., Marcinkiewicz, L., Zhang, Y., Kim, J., Heister, S., Kefas, B., Godlewski, J., Schiff, D., Purow, B., and Abounader, R. (2013) Oncogenic effects of miR-10b in glioblastoma stem cells. J. Neurooncol. 112, 153-163
30. Zhou, X., Ren, Y., Moore, L., Mei, M., You, Y., Xu, P., Wang, B., Wang, G., Jia, Z., Pu, P., Zhang, W., and Kang, C. (2010) Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status. Lab. Invest. 90, 144-155
31. Godlewski, J., Nowicki, M. O., Bronisz, A., Williams, S., Otsuki, A., Nuovo, G., Raychaudhury, A., Newton, H. B., Chiocca, E. A., and Lawler, S. (2008) Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res. 68, 9125-9130
32. Guessous, F., Zhang, Y., Kofman, A., Catania, A., Li, Y., Schiff, D., Purow, B., and Abounader, R. (2010) microRNA-34a is tumor suppressive in brain tumors and glioma stem cells. Cell Cycle 9, 1031-1036
33. Yaniv, K., and Yisraeli, J. K. (2002) The involvement of a conserved family of RNA binding proteins in embryonic development and carcinogenesis. Gene 287, 49-54
34. Vainer, G., Vainer-Mosse, E., Pikarsky, A., Shenoy, S. M., Oberman, F., Yeffet, A., Singer, R. H., Pikarsky, E., and Yisraeli, J. K. (2008) A role for VICKZ proteins in the progression of colorectal carcinomas: regulating lamellipodia formation. J. Pathol. 215, 445-456
35. Köbel, M., Weidensdorfer, D., Reinke, C., Lederer, M., Schmitt, W. D., Zeng, K., Thomssen, C., Hauptmann, S., and Hüttelmaier, S. (2007) Expression of the RNA-binding protein IMP1 correlates with poor prognosis in ovarian carcinoma. Oncogene 26, 7584-7589
36. Trent, J., Meltzer, P., Rosenblum, M., Harsh, G., Kinzler, K., Mashal, R., Feinberg, A., and Vogelstein, B. (1986) Evidence for rearrangement, amplification, and expression of c-myc in a human glioblastoma. Proc. Natl. Acad. Sci. U.S.A. 83, 470-473
37. Fraser, M. M., Zhu, X., Kwon, C. H., Uhlmann, E. J., Gutmann, D. H., and Baker, S. J. (2004) Pten loss causes hypertrophy and increased proliferation of astrocytes in vivo. Cancer Res. 64, 7773-7779
38. Yue, Q., Groszer, M., Gil, J. S., Berk, A. J., Messing, A., Wu, H., and Liu, X. (2005) PTEN deletion in Bergmann glia leads to premature differentiation and affects laminar organization. Development 132, 3281-3291